The Supreme Court Declines to Rule on Mifepristone, Leaving Access in Legal Limbo

In the Food and Drug Administration v. Alliance for Hippocratic Medicine, the accessibility of mifepristone was left at the hands of the Supreme Court. They determined it needed to be decided at lower courts, and we await continued legal challenges.